-
2025.12.15
SUPPLEMENTAL ANNOUNCEMENT
REGARDING CANCELLATION OF BOOK CLOSURE PERIOD
-
2025.12.12
PROXY FORM FOR THE 2025 THIRD EXTRAORDINARY GENERAL MEETING TO BE HELD ON DECEMBER 30, 2025
-
2025.12.12
NOTICE OF THE 2025 THIRD EXTRAORDINARY GENERAL MEETING
-
2025.12.12
(1) PROPOSED ABOLISHMENT OF THE BOARD OF SUPERVISORS; (2) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; (3) PROPOSED AMENDMENTS TO THE RULES OF PROCEDURE FOR SHAREHOLDERS' MEETINGS; (4) PROPOSED AMENDMENTS TO THE RULES OF PROCEDURE FOR THE BOARD OF DIRECTORS; AND (5) NOTICE OF THE 2025 THIRD EXTRAORDINARY GENERAL MEETING
-
2025.12.12
(1) PROPOSED ABOLISHMENT OF THE BOARD OF SUPERVISORS;
(2) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION;
(3) PROPOSED AMENDMENTS TO THE RULES OF PROCEDURE FOR
SHAREHOLDERS' MEETINGS;
(4) PROPOSED AMENDMENTS TO THE RULES OF PROCEDURE FOR
THE BOARD OF DIRECTORS
-
2025.12.08
ANNOUNCEMENT -
BOOK CLOSURE PERIOD FOR
THE 2025 THIRD EXTRAORDINARY GENERAL MEETING
-
2025.12.04
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2025
-
2025.11.20
VOLUNTARY ANNOUNCEMENT THE SIX-MONTH CLINICAL FOLLOW-UP RESULTS FOR LARGE ANNULUS PATIENTS OF LUX-VALVE PLUS TRINITY STUDY AND CLINICAL APPLICATION RESULTS FOR LARGE ANNULUS PATIENTS OF KEN-VALVE RELEASED AT PCR LONDON VALVES 2025, DEMONSTRATING LARGE SIZE ADVANTAGES WITH PRODUCT UNIQUENESS
-
2025.11.06
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2025
-
2025.10.31
CLARIFICATION ANNOUNCEMENT